Harpoon Shareholder Sues For Records On $680M Merck Buy

By Leslie A. Pappas · March 7, 2024, 6:58 PM EST

A shareholder of Harpoon Therapeutics Inc. sued in Delaware's Court of Chancery Thursday for corporate documents related to the company's proposed $680 million cash buyout by Merck, saying the proposed deal...

To view the full article, register now.